Medical/Pharmaceuticals
FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test
SINGAPORE, May 28, 2026 /PRNewswire/ -- Gene Solutions
Want to Stay Current on Latest in Cancer Prevention and Treatment? Free Service from NCCN Can Help
Weekly updates from the National Comprehensive Cancer Network share every time a change is made to evidence-based, expert consensus-driven guidelines for cancer prevention, screening, treatment, and supportive care. PLYMOUTH MEETING, Pa., May 27, 2026 /PRNewswire/ -- The National Comprehensive C...
Metabolon Expands Global Access to Metabolomics with the Metabolon Verus™ Metabolomics Profiling Kit
Democratizing metabolomics for researchers worldwide, the new kit brings
Metabolon's analytically rigorous, scalable metabolomics into workflows
designed for integrated biological insights
MORRISVILLE, N.C., May 27, 2026 /PRNewswire/ -- Metabolon
From Hit Identification to Lead Optimization: Building Scientific Continuity in Early Drug Discovery
SHANGHAI, May 27, 2026 /PRNewswire/ -- On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, "Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated Screening & Chemistry." Moderated by Victoria Ouroutzoglou, the roundtable featured Dr. Bing Xia, Vice...
Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
- Final results from the ENSURE study demonstrate that the addition of elebsiran resulted in a higher functional cure rate compared with pegylated interferon alfa (PEG-IFNα) alone - Data from Cohort 4 suggested that participants responding to prior BRII‑179 treatment achieved the most robust fun...
Fosun International Recognized on Fortune's 2026 "Most Admired Chinese Companies" List
HONG KONG, May 27, 2026 /PRNewswire/ -- On 27 May 2026, Fortune China magazine released its 2026 list of "Most Admired Chinese Companies", in which Fosun International Limited ("Fosun International" or the "Company") (HKEX stock code: 00656) was included in the Industry Star List. This highlights...
CGBIO Signs Global Clinical and Exclusive Commercialization Agreement for NOVOSIS in the U.S., Canada and Australia
* DePuy Synthes secures exclusive commercialization rights in North America and Australia; the two companies to jointly advance global clinical development and regulatory approvals, including FDA IDE and PMA pathways * Full-scale entry into North America, the world's largest bone graft substi...
CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity
Acquisition strengthens U.S. peptide manufacturing capabilities and broadens global expertise in complex peptide APIs * CordenPharma has entered into an agreement to acquire AmbioPharm, a U.S.-headquartered peptide CDMO with facilities in North Augusta, South Carolina (USA) and Shanghai (China...
Doceree, Healthcare Marketing's AI-Powered Operating System, Earns Frost & Sullivan's 2026 Global Technology Innovation Leadership Recognition
Doceree is recognized as the AI leader in healthcare marketing for unifying the
full prescription journey — from physician awareness to fill — on a single,
clinically intelligent operating system.
SAN ANTONIO, May 26, 2026 /PRNewswire/ -- Frost & Sullivan
Beyond the Millimeter: NaoTrac Redefines Precision Standards via Intelligent Surgical Navigation
ZHUBEI, May 26, 2026 /PRNewswire/ -- Precision and minimally invasive are more than technical goals—they are a pledge to uphold patient dignity. In the high-stakes realm of neurosurgery, where the brain's complexity leaves only a millimeter of room for error, the demand for perfection is redefini...
MatOrtho announces ReCerf® 5A* ODEP rating
LEATHERHEAD, England, May 26, 2026 /PRNewswire/ -- MatOrtho is pleased to
announce that ReCerf® has been awarded a 5A* rating by the Orthopaedic Data
Evaluation Panel (ODEP), representing the highest available rating at the
five-year benchmark for orthopaedic implants.
DOSIsoft Launches DOSIsoft Theranostics, a Dedicated Entity to Accelerate Software Innovation for Personalized Nuclear Medicine and Theranostics
PARIS, May 26, 2026 /PRNewswire/ -- Ahead of SNMMI 2026, DOSIsoft
Venus Medtech Hosts Inaugural Global Partner Summit in Paris
Company highlights international growth strategy, expanding structural heart portfolio, and commercialization priorities PARIS, May 26, 2026 /PRNewswire/ -- Venus Medtech convened its inaugural Global Partner Summit in Paris under the theme "Insights, Innovation, Impact," bringing together distr...
Lundbeck receives marketing authorization for Vyepti® (eptinezumab) in South Korea for the preventive treatment of migraine
* Approval granted by South Korea's Ministry of Food and Drug Safety (MFDS) * Eptinezumab is an anti-calcitonin gene-related peptide (CGRP) monoclonal antibody for the preventive treatment of migraine in adults * Authorization supported by the Phase 3 SUNRISE trial conducted in a predominant...
"The Era of Cuffless is Here"… Ring-Type Blood Pressure Monitor 'CART BP pro' Becomes World's First to Be Integrated into Official Hypertension Guidelines
SEOUL, South Korea, May 26, 2026 /PRNewswire/ -- Sky Labs (CEO Jack ByungHwan Lee) announced on the 26th that its ring-type cuffless blood pressure monitor, 'CART BP pro,' has been officially integrated into the'2026 Korean Society of Hypertension Guidelines for the Management of Hypertension (6t...
Global Times: How mutual commitment of Xizang and medical aid workers improves local healthcare
BEIJING, May 26, 2026 /PRNewswire/ -- National support for Xizang's development has yielded remarkable achievements. Over the decades, numerous volunteers from across the country have come to Xizang, making indispensable contributions to the autonomous region's growth. Their efforts focus on vari...
Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)
* This positive CHMP opinion is based on results from the Phase 3 BREAKWATER trial, which showed that encorafenib in combination with cetuximab andmFOLFOX6 demonstrated a statistically significant improvement in the dual primary endpoints of objective response rate (ORR) and progression-free s...
Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
* Data spans seven presentations across both solid tumors and hematologic malignancies, providing updates on the potential benefit these therapies may bring to patients. * Data from the elacestrant plus capivasertib regimen of the ELEVATE study will be presented underscoring its potential i...
THE FUTURE OF MEN'S HEALTH IS MEASURABLE: EMAGENE.LIFE AND ADAM HEALTH PARTNER TO ADVANCE PRECISION LONGEVITY AND FUNCTIONAL MEDICINE
Emagene.life integrates advanced biodata intelligence, functional medicine, and Avio Health AI technology through a strategic collaboration with Adam Health to support measurable male vitality and longevity. KUALA LUMPUR, Malaysia, May 25, 2026 /PRNewswire/ -- Men's health is entering a new era ...
/C O R R E C T I O N -- Medtronic plc/
In the news release, "Medtronic Singapore partners with Society of Colorectal Surgeons to strengthen surgical training", issued on May 25 2026 by Medtronic over PR Newswire, we are advised by the company that the caption text accompanying the image, should read "From left to right: Sharon Lew (Se...
Week's Top Stories
Most Reposted
SMU School of Accountancy launches Applied AI Track for next generation of accounting and finance professionals
[Picked up by 282 media titles]
2026-10-07 11:50DayOne Files Registration Statement for Proposed Initial Public Offering
[Picked up by 279 media titles]
2026-10-06 05:28Agoda Partners with Marina Bay Sands on Bespoke Flagship Store for Experience-Led Travel
[Picked up by 277 media titles]
2026-10-08 09:50New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 273 media titles]
2026-10-09 13:21The Coffee Bean & Tea Leaf® Turns 63 and Sets a New Direction for Its Next Chapter of Growth
[Picked up by 263 media titles]
2026-10-05 13:24